![Jeffrey Tong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Jeffrey K.
Tong is currently Executive Chairman at Ambys Medicines, Inc. since 2021.
He is Chairman at Septerna, Inc. since 2021, Director at Asher Biotherapeutics, Inc., Director at Terremoto Biosciences, Inc., and Partner at Third Rock Ventures LLC since 2016.
Former roles include President & Chief Executive Officer at Nora Therapeutics, Inc. from 2010 to 2015, Chief Executive Officer at Marea Therapeutics, Inc., Chairman at Delinia, Inc. from 2016 to 2017, Independent Director at Nurix Therapeutics, Inc. from 2018 to 2022, Independent Director at Maze Therapeutics, Inc., Director at Regeneration NewCo, Inc., Non-Executive Director at Rapport Therapeutics, Inc. in 2024, Consultant at McKinsey & Co., Inc., and Vice President-Corporate & Product Development at Infinity Pharmaceuticals, Inc. Education includes undergraduate degree from Harvard College, graduate and doctorate degrees from Harvard University, and a graduate degree from Harvard Medical School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SEPTERNA, INC. -.--% | 26/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SEPTERNA, INC. | Presidente | 01/11/2021 |
Ambys Medicines, Inc.
 Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Presidente | 13/12/2018 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Director/Miembro de la Junta | - |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Miembro de la Junta | - |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Inversor de Capital Privado | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director/Miembro de la Junta | 07/11/2024 |
Regeneration NewCo, Inc.
 Regeneration NewCo, Inc. Financial ConglomeratesFinance Operates as a development stage company | Director/Miembro de la Junta | 29/12/2023 |
| NURIX THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/05/2022 |
Delinia, Inc.
 Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Presidente | 01/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 16 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delinia, Inc.
Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
Ambys Medicines, Inc.
Ambys Medicines, Inc. Pharmaceuticals: MajorHealth Technology Develops regenerative medicine therapies for serious liver diseases | Health Technology |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Regeneration NewCo, Inc.
Regeneration NewCo, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
